Welcome to Delicate template
Header
Just another WordPress site
Header

Taking an aspirin a day may lower cancer risk.

Individuals took a minimum of 75mg a day of aspirin for 6 years. Twenty years later, these individuals had a 24% lower risk of developing colon cancer in the first place, and a 35% lower risk of death from colon cancer as compared to placebo.

This was especially important because the some of the cancers studied are found in a part of the colon that is not easily seen with current screening tests.

The populations studied were males at cardiovascular risk. Forty percent of the patients were smokers and most were males. Therefore, the effectiveness of aspirin for non-smokers or females is not known.

 “Cross-talk” between cancer and immune cells.

We have long known that there is “cross-talk” between cancer and immune cells. Immune cells affect the growth of cancer cells and cancer cells affect immune cell inflammatory responses.

Inflammation and Cancer.

Studies have shown that patients with inflammatory bowel diseases, such as ulcerative colitis, or Crohn’s disease, are more likely to develop gastrointestinal cancers than the general population.

Inflammation of the gut occurs with the release of inflammatory cytokines and other immune molecules. They have been shown to contribute to the development and growth of gastrointestinal cancers.

Aspirin regulating immune balance.

Thus aspirin may be helping to regulate the body’s inflammatory responses, and helping to keep the body in immune balance, immune homeostasis.

 
www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62110-1/abstract

www.ncbi.nlm.nih.gov/pmc/articles/PMC2866629/

www.ncbi.nlm.nih.gov/pubmed/18473765

 

Recently, a professional networking site directed me to a short note by Lisa Moreno-Dickinson, President of the stopcaidnow.org. The title of her article was “When Doctors Don’t Know How to Help From Misdiagnosis to No diagnosis … What Can a Parent Do?”.

CAID refers to Childhood Auto Inflammatory Diseases. These genetic disorders usually start in infancy or childhood and are reported to be the result of gene mutations. The periodic attacks of these conditions affect many different organ systems. They are characterized by sudden inflammation and fever onset, and symptoms such as rashes, headache, abdominal, chest, muscle, and joint pains, swollen joints and scrotum.

Much of the science suggests that these conditions are not autoimmune in nature. These individuals have no any significant elevations of autoantibodies, immunoglobulins, large immune molecules that are directed against self, nor activation of specific white blood cells.

Our knowledge of the complexities of the immune system, especially its inflammatory pathways, are still in their infancy as supported by the fact that cancer, colds, infectious, and chronic diseases are rampant.

I respectfully suggest that perhaps autoinflammatory investigators have not used the appropriate assay to find autoimmune responses because a) it does not exist yet, or b) it is difficult to “test for everything”.

A recent report suggests that there is an association between autoinflammatory conditions and mitochondrial health. Mitochondria are the power stations of a cell that provides it with the energy it needs to grow, divide, and “do its job”. They play major roles in healthy aging, degenerative diseases, cancer, and ultimately, cell death. The greater its metabolic or energy requirements, the more mitochondria a cell appears to have. As an example, a muscle cell may have thousands of mitochondria and a skin cell only a few hundred.

Antibodies to mitochondrial proteins have been reported in autism spectrum disorders, which are attributed to inflammatory conditions of the nervous system. Additionally children with severe autism have higher levels of inflammatory cytokines and certain immune molecules than controls.

In Blau’s syndrome, an autoinflammatory disease, symptoms are associated with the skin, joints, and eyes. It is often mistaken for sarcoidosis, a known autoimmune disease of the skin and other organs. Crohn’s disease is an inflammatory autoimmune bowel disease in which the immune system attacks its own digestive lining.

There are two genes, NOD1 and NOD2 that help regulate the production pro-inflammatory cytokines, immune molecules that cause inflammation. Mutations of these genes are found in a number of inflammatory disorders including Blau’s syndrome, sarcoidosis, and inflammatory bowel diseases.

Investigations of the pivotal role of gene regulation of inflammatory responses are underway; however, ways to neutralize the effects of such mutations may be years away.

Parents and clinicians do not have the luxury of just waiting. We know that inappropriate inflammatory responses are occurring in many, so why not determine whether the re-introduction of immune homeostasis, immune balance would make a difference in their quality of life?

 

www.parentsociety.com/parenting/when-doctors-dont-know-what-to-do-or-how-to-help/?goback=%2Egde_151241_member_74525704

www.ncbi.nlm.nih.gov/pmc/articles/PMC2735099/

www.ncbi.nlm.nih.gov/pubmed/16466630

www.ncbi.nlm.nih.gov/pubmed/21453638

www.ncbi.nlm.nih.gov/pubmed/21083929

www.ncbi.nlm.nih.gov/pubmed/21735170

www.ncbi.nlm.nih.gov/pubmed/18368292

www.ncbi.nlm.nih.gov/pubmed/21521652

www.ncbi.nlm.nih.gov/pubmed/21433392

 

Today, three immunologists, Drs. Ralph Steinman*, Jules Hoffman, and Bruce Beutler, won the Nobel Prize in Medicine/Physiology for adding to our scant knowledge of immune system responses to pathogenic microorganisms and cancer cells. Their studies should also provide a better understanding as to how excessive inflammation leads to autoimmunity, attacks on the body’s own healthy tissues.

Two decades ago Dr. Ralph Steinman and his colleague, Dr. Zanvil Alexander Cohn at the Center for Immunology and Immune Diseases, Rockefeller University in New York City, described dendritic cells, specialized immune cells that interact with other immune cells to define how the body will respond to underlying infection and disease.

Dendritic cells are essential to the body’s ability to control immune inflammatory homeostasis. Immune homeostasis is the delicate balance of all immune responses, especially inflammatory and anti-inflammatory responses, that that the body uses to fight disease. Too little inflammation may result in uncontrolled growth of pathogens or cancer cells, whereas too much inflammation, may result in autoimmune conditions such as diabetes, arthritis, lupus, multiple sclerosis, Crohn’s disease, etc.

Part of the role of immune homeostasis is to determine “what comes next” in meeting immune challenges. Dr. Steinman and his colleagues described an important phase of the immune response, “maturation”, which helps the body determine inflammatory and other responses to infection.

Dendritic cells are also important in helping the body maintain immunological “memory”. This assures a more rapid and thorough immune response if is attacked by the same pathogen another time. [Successful immunization depends on immunological memory.]

Dr. Jules Hoffman and his team, described how the immune system first recognizes invading pathogens and then helps trigger the immune system to go into its protective mode.

Dr. Beutler discovered the inflammatory cytokine, tumor necrosis factor, TNF, and a marker on certain bacterial cells that helps the body recognize that it has been infected, so that it can mount an appropriate inflammatory attack.

www.nobelprize.org/nobel_prizes/medicine/laureates/2011/press.pdf

www.rockefeller.edu/labheads/steinman/pdfs/2003-APMI.pdf

www.ncbi.nlm.nih.gov/pubmed/21960036

www.wrvo.fm/post/nobelists-showed-how-immune-defenses-work-and-go-awry

*The Nobel Committee has expressed “deep sadness and regret” at the news that Dr.
Steinman died a few days before its announcement.   Typically, the Nobel Prize is not awarded posthumously, but the Committee has decided to proceed with bestowing the award on Dr. Steinman.

According to the World Health Organization smoking is the second largest preventable cause of disease and premature death. Globally, tobacco products are responsible for 5 million deaths annually. A person dies every 6 seconds from smoking-related diseases including chronic diseases and cancer.

Among its many effects, smoking triggers an immunologic response in arteries and veins which is associated with increased levels of inflammatory markers, such as C-reactive protein and increases in white blood cells. C-reactive protein is strongly associated with lifetime smoking exposure as measured by pack-years. Several studies have shown that such markers predict future cardiovascular events including atherosclerosis.

However, once smokers quit, their risk of future cardiac events and death gradually declines, and within 5 years, smoking-associated inflammatory responses start to return to normal.

Cigarette smoking has also been linked to increased risk of autoimmune diseases, including lupus, rheumatoid arthritis, multiple sclerosis, thyroid, and liver. Autoimmune diseases are immune disorders where the body attacks itself resulting in excessive inflammation and tissue damage.

Considering that cigarette smoke contains over 7000 chemicals, the likelihood that smoking triggers autoimmune and other excessive inflammatory immunological responses makes sense. An example of smoke-induced illness is chronic obstructive pulmonary disease (COPD) in which a person has difficulty in getting enough air.

The lungs, in response to cigarette smoke, activate cells lining the lungs and immune cells, resulting in inflammatory responses. If an individual is infected with a bacterial or viral infection in addition to the smoke assault, it results in a vicious cycle of more difficulties in breathing and greater inflammation. Studies have indeed shown that patients with COPD have autoantibodies and inflammatory responses against lung cells.

Researchers have reported that in female smokers, physical activity, known to help reduce inflammation, reduced their relative risk of developing lung cancer by more than 65 percent.

Thus, it might be expected that if smokers were better able to control their inflammatory responses and return to immune homeostasis, that they might be less likely to develop chronic diseases.

 

www.ncbi.nlm.nih.gov/pmc/articles/PMC1160597/

www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020160

www.ncbi.nlm.nih.gov/pubmed/21907865

www.ncbi.nlm.nih.gov/pubmed/17975205

www.medicalnewstoday.com/releases/58661.php

 

It is ten years since the horrific 9/11/01 attacks on the World Trade Center in New York City, The Pentagon in Washington, DC, and Flight 93 in Pennsylvania. On that day at the World Trade Center alone, there were approximately 3,000 murders.

These events have not only left the families, friends, and citizen survivors distraught and at great emotional and financial risk, but the heroic responders, the rescuers, recovery, and clean-up personnel, and civilians that lived and worked in the area, continue to pay a significant price in terms of their health.

There will never be a true accounting of how many individuals were exposed to smoke, thick-coatings of dust, combustion materials, asbestos, polychlorinated biphenyls (PCBs), dioxin, asbestos, and metals. Fire fighters, police, military members, paramedics, construction and iron workers, municipal employees, security workers, residents and workers in the area, and those that came from afar to help, were exposed to these toxic chemicals for days, weeks, and months. Fires burned for 69 days and even eight months after the destruction, workers were still searching for body fragments (1).

For some, the years may be receding from memory, but there are many individuals, and rescue and recovery dogs, that have, or are, still, paying a significant price for their heroic sacrifices. If they are still alive, their emotional and physical health has declined significantly, and no one seems to be able to help them.

Only limited funding has been available to study and monitor individuals that were at Ground Zeroand its surrounding environs. When researching information for this article I was surprised at the relatively few, peer-reviewed publications on this topic, and there is even less information on the effects of this trauma on children and adolescents.

Multiple Health Issues

A primary investigation now led by Dr Juan Wisnivesky, Mount Sinai School of Medicine in New York, has said, “Our findings show a substantial burden of persistent physical and mental disorders in rescue and recovery workers who rushed to the site of the WTC and labored there for weeks and months. Many of these individuals now suffer from multiple health problems (2), since World Trade Center-related mental and physical health conditions often co-exist (3).

Mental Health Issues Persist

One year after 9/11, it was estimated that more than 420,000 people New Yorkers were suffering from post traumatic stress disorders (PTSD) as a result of the attacks (1). This month, the prestigious British journal, Lancet, reports that 32% of tested personnel experienced post traumatic stress disorders and 28% per cent experienced depression at some time after 9/11. The incidence of most of the disorders was highest in workers with greatest World Trade Center exposure (3,4). Other emotional problems such as recurring nightmares, flashbacks, self-medication with alcohol, etc. have also been persistent issues.

Tomorrow: 9/11 Responders: Cancer Risks, Pulmonary Function, Immune Homeostasis, Balance.

1) www.guardian.co.uk/world/2002/aug/18/usa.terrorism

2) www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61180-X/abstract

3) www.guardian.co.uk/world/2011/sep/02/world-trade-centre-rescuers-health-risk

4) www.thelancet.com/journals/lanonc/article/PIIS1470-2045(01)00543-5/fulltext

Inflammatory Homeostasis, Cancer and Fatigue

| Posted by in Cancer | Fatigue | Immune Homeostasis (Immune Balance) - (Comments Off on Inflammatory Homeostasis, Cancer and Fatigue)

In today’s Wall Street Journal*, Jonathan Rockoff reports on new cancer treatments that are “personalized” depending on whether one is carrying a certain mutated gene. When individuals with specific types of cancer carry the mutated gene, and are treated with these new medications, the results are impressive. Almost 50% of cancer patients taking these medications had shrinkage of tumors compared with 5.5% of those on conventional chemotherapy.

Some patients taking the medications report side effects such as fatigue and joint pain which led their physicians to lower their dose. Fatigue and joint pain are signs of immune dysfunction, typically excessive levels of inflammatory responses by the immune system. The key is to help the body return to immune homeostasis (immune balance).

Immune inflammation has two main functions: a) defending the body from infection, and b) healing the body when an infection has occurred, or if the body injured.

People are becoming increasingly aware that inflammation is also associated with other conditions such as atherosclerosis (1), autoimmune conditions, and even the development of cancer [2, 3].
The relationship between immune inflammation and cancer is not well understood, but it appears that inflammatory responses feed cancer cells and cancer cells trigger inflammatory responses.

The relationship between cancer and inflammation is not simple (4). But studies suggest that if approximately 15 percent of cancer [5], is associated with microbial infection one would expect that if infections were reduced world-wide, so would cancer.

There are certain “hallmarks of cancer” [4]:

Cancer cells:
Are often “immortal”. In a test tube, whereas “normal” cells will divide a number of times before they die off, cancer cells keep dividing and multiplying for a long time—they seem to disregard the natural “death” cycle.

Appear to stimulate blood vessels to grow to them bringing them “good blood circulation” and nutrients.

Are independent—they can grow without input or control from other cells.

Lack “contact-inhibition”. [Normal cells will stop growing when they touch one another, cancer cells will “overgrow” each other.]
Are able to invade other tissues and spread throughout the body (metastasize).

Some scientists consider pre-malignant tumors as being “wound-like” [6]. The body recognizes the presence of the tumor and starts to combat it using inflammation as its weapons system.

The inflammatory response produces immune factors that recruit other inflammatory immune cells into the area to “heal” the “lesion”. Unfortunately however, due to the nature of cancer cells, some of these molecules may only stimulate the growth of more cancer cells resulting in more tissue invasion and metastasis [7]. This is why immune homeostasis is essential to our health.

Taking the following steps may help decrease the chances of getting cancer:
a) Stop the use of tobacco.
b) Drink alcohol in moderation (if you consume alcohol).
c) Have moderate sun exposure (10 minutes/day) and plenty of fresh air.
d) Eat plant-based foods, especially those high in phytonutrients: berries, dark, green, leafy vegetables, cauliflower, broccoli, nuts (in moderation), are great choices.
e) Increase your physical activity. (Physical activity is associated with a reduced risk of cancers of the colon and breast, improved quality of life among cancer patients, and cancer survival (8)).
f) Maintain a healthy weight (obese people have higher rates of cancer)
g) Avoid risky sexual and chemical-abuse behaviors that may expose you to certain infections that may lead to cancer (for example: HIV/AIDS, hepatitis, etc.)
h) Screen regularly for cancer

Also, to help the body achieve inflammatory immune homeostasis, along with eating a healthful diet and controlling your portion sizes, consumption of on a daily basis of hyperimmune egg is prudent.

*http://online.wsj.com/article/SB10001424053111903639404576514084262209282.html

1. Crandall MA, Corson MA. Curr Treat Options Cardiovasc Med. 2008 10:304.
2. Balkwill F, Mantovani A. Lancet. 2002 357:539.
3. Coussens LM, Werb Z. Nature. 2002 420:860.
4 Hanahan D, Weinberg RA. Cell. 2000 100:57.
5. Kuper H, et al. J Intern Med. 2000 248:171.
6. Coussens LM, et al. Genes Dev. 1999 13:1382.
7. Rakoff-Nahoum S. Yale J Biol Med. 2006 79:123
8. http://www.cancer.gov/newscenter/pressreleases/PhysicalActivity

css.php